Magnetic resonance imaging for prediction of pathologic response to neoadjuvant chemotherapy in triple-negative breast cancer. Issue 2 (February 2019) - Golshan, M.; Wong, S.; Loibl, S.; Huober, J.B.; O'Shaughnessy, J.; Rugo, H.S.; Wolmark, N.; McKee, M.D.; Maag, D.; Sullivan, D.M.; Metzger-Filho, O.; Von Minckwitz, G.; et al.